Clinical Trials
25 trialsLUPARPED
Fundación de investigación HM
NET-COMPARE
British Columbia Cancer Agency
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
SJFAMILY
St. Jude Children's Research Hospital
Prospective Cohort Study of Pheochromocytoma/Paraganglioma
Peking Union Medical College Hospital
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
Columbia University
LAMPARA
Columbia University
In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
Abramson Cancer Center at Penn Medicine
Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)
Peking University First Hospital
PHEO
University Hospital, Rouen
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
Institutional Registry of Rare Diseases
Hospital Italiano de Buenos Aires
Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas
Laikο General Hospital, Athens
Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma
Peking Union Medical College Hospital
DOMINO-START
Weill Medical College of Cornell University
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
The University of Texas Health Science Center at San Antonio
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
Nanjing First Hospital, Nanjing Medical University
Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors
Peking University First Hospital
BELIEVE-VHL
AC Camargo Cancer Center
Ivonescimab in the Treatment of Multiple Advanced Tumors
Fudan University
Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
University of Pennsylvania
PRONO-PARAG
Hospices Civils de Lyon
CABATEN
Grupo Espanol de Tumores Neuroendocrinos